Abbott India Ltd (ABBOTINDIA) — Announcement | 28 September 2026
Abbott India has closed its insider trading window effective October 1, 2026, until two days after reporting Q2 results on September 30, 2026, to comply with SEBI regulations. This restricts trading by designated insiders and their families during a sensitive financial period.
About Abbott India Ltd (ABBOTINDIA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when ABBOTINDIA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ABBOTINDIA — Free💡 Ask AI about this filing
📊 More ABBOTINDIA filings
- 🔴 Announcement — 7 September 2026Abbott India announced the resignation of its Company Secretary and Compliance Officer, Ms. Sangeeta...
🔥 Also filed on 28 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ABBOTINDIA files new disclosures
Track ABBOTINDIA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ABBOTINDIA — FreeFree account · 2 AI queries/day